- Home
- Equipment
- usa pennsylvania
- cancer risk
Show results for
Refine by
Cancer Risk Equipment & Supplies In Usa Pennsylvania
34 equipment items found
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer risk-associated biomarkers in patient urine sample or biopsy tissue sample to distinguish high-risk and aggressive prostate cancer needing immediate treatment from low-risk and indolent prostate ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Empower screens for genes associated with increased risk for common hereditary cancers. Our Empower ...
Manufactured by:Spark Mobile Diagnostics based inJamnagar, INDIA
Lateral flow “Sandwich” Assay with technology developed by US experts in industry; Detects both Vitamin D2 and D3 in range of 4 ng/ml – 100 ng/ml; High specificity – No Interference of Biotin; Ideal screening test for Physicians clinics, OB/GYN, Orthopedics and general wellness ...
Manufactured by:Time Medical Holding based inShatin, CHINA
The EMMA 1.5T MRI is designed to offer breast imaging centers a new adjunctive tool to their current equipment options. Emma is a whole body MRI with dedicated breast coils for exclusive high-quality imaging. In collaboration with leading breast cancer centers and following new published trends, the EMMA system extends MRI's strong diagnostic utility with rapid and cost-effective - optimal ...
Manufactured by:IceCure Medical Ltd based inCaesarea, ISRAEL
We are dedicated to providing reliable clinical support for the ProSense™ System, so that physicians and other stakeholders can adopt our technology with confidence as the gold standard in tumor therapy. ICE3 is the largest controlled multilocation clinical trial ever performed for liquid nitrogen (LN2) –based cryoablation of small, low-risk, early-stage malignant breast tumors ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
Multigene prognostic test predicts the probability of metastasis or recurrence, which helps patients make treatment decision. It improves quality of life for cancer patients as preventing them from unnecessary ...
by:Imagin Medical based inAuburndale, MASSACHUSETTS (USA)
The conventional method of detecting bladder cancer uses white light during minimally invasive surgery to illuminate the bladder during a procedure called a cystoscopy. White light has been used for decades and is the standard for more than 90% of the market. In typical white light cystoscopy, a small camera is mounted at the end of the cystoscope. ...
by:Ezra based inGeorgetown, TEXAS (USA)
Ezra offers advanced MRI-based full-body scans aimed at early cancer detection. The service employs 3 Tesla (3T) MRI technology, known for its higher-resolution imaging and superior signal-to-noise ratio, alongside 1.5 Tesla (1.5T) MRI for broader accessibility. These scans are designed to identify potential early-stage cancers, significantly improving survival ...
Manufactured by:Nucleix Ltd. based inSan Diego, CALIFORNIA (USA)
Bladder cancer is the 5th most common cancer in the western world, and 70%-80% of the patients are diagnosed with non-muscle invasive disease. There are estimated 400,000 to 800,000 active bladder cancer patients in the United States, as well as 1 to 2 million in Europe, who undergo local resection of the tumor and then have 1-4 follow-up visits each year due to the high recurrence rate of the ...
Manufactured by:PreludeDx based inLaguna Hills, CALIFORNIA (USA)
Predicts radiation benefit. DCISionRT is the only test capable of predicting an individual patient’s benefit from radiation therapy. Using DCISionRT provides you with 10-year Total and Invasive Recurrence Risk after breast conserving surgery as well as surgery with radiation therapy. No other test can do ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
Manufactured by:Mesothelioma + Asbestos Awareness Center based inSyracuse, NEW YORK (USA)
Lung cancer is one of the most common cancers, and researchers estimate about 3 – 4% of all cases can be attributed to asbestos ...
Manufactured by:MD Diagnostics Ltd based inChatham, UNITED KINGDOM
Dental professionals have a unique opportunity to address smoking with patients in a manner that will make a difference. Brief advice from a dentist or member of the dental team has been shown to increase a patient’s motivation to quit and can double a patient’s success with ...
Manufactured by:20/20 GeneSystems Inc. based inRockville, MARYLAND (USA)
Comprehensive health screening, something common in many countries outside of the U.S. has been something that is rarely accessible for most Americans. By placing a high priority on early detection, most cancers can be survivable when detected early enough to be surgically removed. Now, 20/20 is bringing a new blood test to the U.S. which can detect the possible presence of five or more cancer ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
INOVIQ has three autoantibody tests in development for early detection of ovarian, breast and lung cancers. BARD1 autoantibody tests measure autoantibodies to variant BARD1 proteins in the blood and use a proprietary cancer-specific algorithm to combine these levels into a cancer score that identifies the presence or absence of a specific cancer. BARD1 autoantibodies reflect the body’s ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
miR Scientific is a precision healthcare company committed to improving public health by transforming cancer management globally. The company’s proprietary miR Disease Management Platform® was developed to revolutionize the standard of value-based care for cancers and initially focuses on urological cancers. The initial test delivered by the miR Disease Management Platform® is the ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant chemotherapy, and in Stage III localized colon cancer to inform them about the optimal treatment duration for their patients. ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
The science behind miR’s prostate and bladder cancer detection and classification technology that can help give healthcare providers, patients, and payors the greatest confidence in test results and care ...
Manufactured by:Rhythm Biosciences Limited based inParkville, AUSTRALIA
The ColoSTAT technology has the potential to become the new, first step screening test for people, who for personal, cultural or clinical reasons, elect to not participate in the existing screening programs for colorectal ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
The QIAsure Methylation Test is a multiplex real-time methylation specific PCR-based (qMSP) assay that detects hyper methylation of 2 disease related marker genes, FAM19A4 and mir124-2, to distinguish women with cervical (pre)cancer. The test specifically detects women with a cancer-like methylation profile, which are indicative for the women who have a ...